Our results showed that phosphatidylinositol (PI)-3-kinase/protein kinase/mammalian targeted of rapamycin (PI3K/AKT/mTOR) signaling pathway was active in cancer cells (Table 3). This evidence concerns the gene MTOR and cancer.